Stonegate Capital Partners Updates Coverage on Aemetis, Inc. (AMTX) Q4 2024
Aemetis (NASDAQ: AMTX) reported significant growth in FY24, with revenues increasing 43% to $268.0 million from $187.0 million in FY23. The company posted a net loss of $87.5 million, primarily due to interest expenses.
Key operational highlights include doubled RNG capacity and a 55% growth in ethanol revenue, driven by sustainability investments. The India Biofuels segment showed strong performance with a 20% revenue increase and 50% production growth, alongside ongoing IPO plans.
The company ended Q4 2024 with $0.898 million in cash, expecting a higher cash position in Q1 2025 following the sale of $16.8 million in transferable investment tax credits in February 2025. Regulatory support through LCFS, E15, and 45Q/45Z credits are identified as potential growth catalysts.
Aemetis (NASDAQ: AMTX) ha riportato una crescita significativa nell'anno fiscale 2024, con ricavi aumentati del 43% a $268,0 milioni rispetto ai $187,0 milioni dell'anno fiscale 2023. L'azienda ha registrato una perdita netta di $87,5 milioni, principalmente a causa delle spese per interessi.
I principali punti operativi includono il raddoppio della capacità di RNG e una crescita del 55% nei ricavi dell'etanolo, sostenuta da investimenti nella sostenibilità. Il segmento Biocarburanti in India ha mostrato una forte performance con un aumento del 20% dei ricavi e una crescita della produzione del 50%, insieme a piani per un'IPO in corso.
L'azienda ha chiuso il quarto trimestre del 2024 con $0,898 milioni in contante, prevedendo una posizione di cassa più elevata nel primo trimestre del 2025 dopo la vendita di $16,8 milioni in crediti d'imposta trasferibili sugli investimenti a febbraio 2025. Il supporto normativo attraverso LCFS, E15 e crediti 45Q/45Z sono identificati come potenziali catalizzatori di crescita.
Aemetis (NASDAQ: AMTX) reportó un crecimiento significativo en el año fiscal 2024, con ingresos aumentando un 43% a $268,0 millones desde $187,0 millones en el año fiscal 2023. La empresa registró una pérdida neta de $87,5 millones, principalmente debido a los gastos por intereses.
Los aspectos operativos clave incluyen el duplicado de la capacidad de RNG y un crecimiento del 55% en los ingresos por etanol, impulsado por inversiones en sostenibilidad. El segmento de biocombustibles en India mostró un rendimiento sólido con un aumento del 20% en los ingresos y un crecimiento del 50% en la producción, junto con planes de OPI en curso.
La empresa cerró el cuarto trimestre de 2024 con $0,898 millones en efectivo, esperando una posición de efectivo más alta en el primer trimestre de 2025 tras la venta de $16,8 millones en créditos fiscales transferibles de inversión en febrero de 2025. El apoyo regulatorio a través de LCFS, E15 y créditos 45Q/45Z se identifican como posibles catalizadores de crecimiento.
Aemetis (NASDAQ: AMTX)는 2024 회계연도에 43% 증가한 $268.0 백만의 수익을 보고하며, 2023 회계연도의 $187.0 백만에서 성장했습니다. 회사는 주로 이자 비용으로 인해 $87.5 백만의 순손실을 기록했습니다.
주요 운영 하이라이트로는 RNG 용량이 두 배로 증가하고, 지속 가능성 투자에 힘입어 에탄올 수익이 55% 성장한 점이 포함됩니다. 인도 바이오연료 부문은 수익이 20% 증가하고 생산이 50% 성장하며 강력한 성과를 보여주었고, IPO 계획도 진행 중입니다.
회사는 2024년 4분기를 $0.898 백만의 현금으로 마감했으며, 2025년 1분기에는 2025년 2월에 $16.8 백만의 양도 가능한 투자 세액 공제를 판매한 후 더 높은 현금 위치를 기대하고 있습니다. LCFS, E15 및 45Q/45Z 크레딧을 통한 규제 지원이 성장 촉진제로 확인되었습니다.
Aemetis (NASDAQ: AMTX) a annoncé une croissance significative pour l'exercice 2024, avec des revenus en hausse de 43% à $268,0 millions contre $187,0 millions pour l'exercice 2023. L'entreprise a enregistré une perte nette de $87,5 millions, principalement en raison des frais d'intérêt.
Les points opérationnels clés incluent un doublement de la capacité de RNG et une croissance de 55% des revenus de l'éthanol, soutenue par des investissements dans la durabilité. Le segment des biocarburants en Inde a montré de solides performances avec une augmentation de 20% des revenus et une croissance de 50% de la production, tout en poursuivant des projets d'introduction en bourse.
L'entreprise a terminé le quatrième trimestre 2024 avec $0,898 millions en espèces, s'attendant à une position de trésorerie plus élevée au premier trimestre 2025 après la vente de $16,8 millions en crédits d'impôt sur les investissements transférables en février 2025. Le soutien réglementaire via LCFS, E15 et les crédits 45Q/45Z sont identifiés comme des catalyseurs de croissance potentiels.
Aemetis (NASDAQ: AMTX) berichtete von einem signifikanten Wachstum im Geschäftsjahr 2024, mit einem Umsatzanstieg von 43% auf $268,0 Millionen im Vergleich zu $187,0 Millionen im Geschäftsjahr 2023. Das Unternehmen verzeichnete einen Nettoverlust von $87,5 Millionen, hauptsächlich aufgrund von Zinsaufwendungen.
Wichtige betriebliche Höhepunkte sind die Verdopplung der RNG-Kapazität und ein Umsatzwachstum von 55% im Ethanolbereich, unterstützt durch Investitionen in Nachhaltigkeit. Das Segment Biokraftstoffe in Indien zeigte eine starke Leistung mit einem Umsatzanstieg von 20% und einem Produktionswachstum von 50%, während die laufenden IPO-Pläne fortgesetzt werden.
Das Unternehmen schloss das vierte Quartal 2024 mit $0,898 Millionen in bar ab und erwartet eine höhere Liquidität im ersten Quartal 2025 nach dem Verkauf von $16,8 Millionen an übertragbaren Investitionssteuergutschriften im Februar 2025. Die regulatorische Unterstützung durch LCFS, E15 und 45Q/45Z-Gutschriften wird als potenzielle Wachstumstreiber identifiziert.
- Revenue growth of 43% to $268.0M in FY24
- Doubled RNG capacity with 55% growth in ethanol revenue
- India Biofuels segment showed 20% revenue growth and 50% production increase
- Expected cash boost of $16.8M from tax credits sale in February 2025
- Net loss of $87.5M primarily from interest expenses
- Low cash position of $0.898M at year-end 2024
Dallas, Texas--(Newsfile Corp. - March 28, 2025) - Aemetis, Inc. (NASDAQ: AMTX): Stonegate Capital Partners updates coverage on Aemetis, Inc. (NASDAQ: AMTX), highlighting strong growth across its renewable energy segments. Full year revenues increased
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Aemetis doubled RNG capacity and grew ethanol revenue by
55% , driven by sustainability investments. - India Biofuels revenue rose
20% , with production up50% and IPO plans underway. - Regulatory support like LCFS, E15, and 45Q/45Z credits offer major tailwinds--pending political clarity.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/246463
FAQ
What was Aemetis (AMTX) revenue growth in FY 2024?
How much was Aemetis (AMTX) net loss in FY 2024?
What was the performance of AMTX India Biofuels segment in 2024?
How much cash did Aemetis (AMTX) have at the end of Q4 2024?
What regulatory support factors could benefit AMTX growth?
